127 related articles for article (PubMed ID: 38442581)
1. CD109 identified in circulating proteomics mitigates postoperative recurrence in chronic rhinosinusitis with nasal polyps by suppressing TGF-β1-induced epithelial-mesenchymal transition.
Gao R; Chen Y; Liu H; Ye M; Chu L; Wang T
Int Immunopharmacol; 2024 Mar; 130():111793. PubMed ID: 38442581
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1 induces epithelial-to-mesenchymal transition in chronic rhinosinusitis with nasal polyps through microRNA-182.
Jiang W; Zhou C; Ma C; Cao Y; Hu G; Li H
Asian Pac J Allergy Immunol; 2024 Mar; 42(1):61-73. PubMed ID: 34953475
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1 Induces Epithelial-Mesenchymal Transition of Chronic Sinusitis with Nasal Polyps through MicroRNA-21.
Li X; Li C; Zhu G; Yuan W; Xiao ZA
Int Arch Allergy Immunol; 2019; 179(4):304-319. PubMed ID: 30982052
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of IL-4/STAT6/IRF4 signaling reduces the epithelial-mesenchymal transition in eosinophilic chronic rhinosinusitis with nasal polyps.
Chen J; Chen S; Gong G; Yang F; Chen J; Wang Y
Int Immunopharmacol; 2023 Aug; 121():110554. PubMed ID: 37385124
[TBL] [Abstract][Full Text] [Related]
5. A Potential Role of B7-H4 Expression in Predicting the Recurrence of Chronic Rhinosinusitis with Nasal Polyps.
Wang F; Chu W; Deng Z; Jing Q; Xie B
J Inflamm Res; 2022; 15():3421-3431. PubMed ID: 35711239
[TBL] [Abstract][Full Text] [Related]
6. TIM-4 in macrophages contributes to nasal polyp formation through the TGF-β1-mediated epithelial to mesenchymal transition in nasal epithelial cells.
Qin D; Liu P; Zhou H; Jin J; Gong W; Liu K; Chen S; Huang J; Fan W; Tao Z; Xu Y
Front Immunol; 2022; 13():941608. PubMed ID: 35990621
[TBL] [Abstract][Full Text] [Related]
7. Multiple cytokine analyses identify CSF1 as a robust biomarker for predicting postoperative recurrence in chronic rhinosinusitis with nasal polyps.
Niu Y; Cao S; Ma X; Xu Z; Wu H
Int Immunopharmacol; 2024 Jan; 127():111430. PubMed ID: 38142640
[TBL] [Abstract][Full Text] [Related]
8. Serum proteomics identify CSF1R as a novel biomarker for postoperative recurrence in chronic rhinosinusitis with nasal polyps.
Niu Y; Cao S; Luo M; Ning J; Wen N; Wu H
World Allergy Organ J; 2024 Mar; 17(3):100878. PubMed ID: 38445296
[TBL] [Abstract][Full Text] [Related]
9. Circulating BAFF as novel biomarker in distinguishing chronic rhinosinusitis with nasal polyps endotypes and predicting postoperative recurrence.
Wang G; Li M; Zheng J; Zhan J; Zheng H; Li R; Wei X
Int Immunopharmacol; 2022 Mar; 104():108515. PubMed ID: 35008009
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-Mesenchymal Transition in Chronic Rhinosinusitis: Differences Revealed Between Epithelial Cells from Nasal Polyps and Inferior Turbinates.
Könnecke M; Burmeister M; Pries R; Böscke R; Bruchhage KL; Ungefroren H; Klimek L; Wollenberg B
Arch Immunol Ther Exp (Warsz); 2017 Apr; 65(2):157-173. PubMed ID: 27393708
[TBL] [Abstract][Full Text] [Related]
11. miR-200a-3p regulates epithelial-mesenchymal transition and inflammation in chronic rhinosinusitis with nasal polyps by targeting ZEB1 via ERK/p38 pathway.
Wu Y; Sun K; Tu Y; Li P; Hao D; Yu P; Chen A; Wan Y; Shi L
Int Forum Allergy Rhinol; 2024 Jan; 14(1):41-56. PubMed ID: 37318032
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of arachidonate 15-lipoxygenase reduces the epithelial-mesenchymal transition in eosinophilic chronic rhinosinusitis with nasal polyps.
Yan B; Wang Y; Li Y; Wang C; Zhang L
Int Forum Allergy Rhinol; 2019 Mar; 9(3):270-280. PubMed ID: 30452122
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expressions of TAM receptors are associated with postoperative recurrence in chronic rhinosinusitis with nasal polyps.
Zhou Y; Feng Z; Wen J; Yang C; Jing Q
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3005-3015. PubMed ID: 38233691
[TBL] [Abstract][Full Text] [Related]
14. Curcumin mitigates the epithelial-to-mesenchymal transition in biliary epithelial cells through upregulating CD109 expression.
Fan J; Wang Q; Zhang Z; Sun L
Drug Dev Res; 2019 Nov; 80(7):992-999. PubMed ID: 31403228
[TBL] [Abstract][Full Text] [Related]
15. miR‑155‑5p downregulation inhibits epithelial‑to‑mesenchymal transition by targeting SIRT1 in human nasal epithelial cells.
Yang N; Cheng H; Mo Q; Zhou X; Xie M
Mol Med Rep; 2020 Nov; 22(5):3695-3704. PubMed ID: 33000196
[TBL] [Abstract][Full Text] [Related]
16. Differing roles for TGF-β/Smad signaling in osteitis in chronic rhinosinusitis with and without nasal polyps.
Wang M; Ye T; Liang N; Huang Z; Cui S; Li Y; Huang Q; Zhou B
Am J Rhinol Allergy; 2015; 29(5):e152-9. PubMed ID: 26265084
[TBL] [Abstract][Full Text] [Related]
17. Profibrotic transforming growth factor beta 1 and activin A are increased in nasal polyp tissue and induced in nasal polyp epithelium by cigarette smoke and Toll-like receptor 3 ligation.
Yamin M; Holbrook EH; Gray ST; Busaba NY; Lovett B; Hamilos DL
Int Forum Allergy Rhinol; 2015 Jul; 5(7):573-82. PubMed ID: 25914020
[TBL] [Abstract][Full Text] [Related]
18. Eupatilin alleviates inflammation and epithelial-to-mesenchymal transition in chronic rhinosinusitis with nasal polyps by upregulating TFF1 and inhibiting the Wnt/β-catenin signaling pathway.
Su H; Zhao Y
Histol Histopathol; 2024 Mar; 39(3):357-365. PubMed ID: 37338164
[TBL] [Abstract][Full Text] [Related]
19. [Pleiomorphism of the cytokine profile in nasal polyp tissue depending on the phenotype of chronic rhinosinusitis with nasal polyps].
Savlevich EL; Zurochka AV; Kurbacheva OM; Egorov VI; Shilovskiy IP; Mitrofanova ES; Lyubimova EV
Vestn Otorinolaringol; 2023; 88(1):50-56. PubMed ID: 36867144
[TBL] [Abstract][Full Text] [Related]
20. CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro.
Zhou S; da Silva SD; Siegel PM; Philip A
Sci Rep; 2019 Nov; 9(1):16317. PubMed ID: 31695056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
